Dr Martin Kaiser is the team leader of the Myeloma Molecular Therapy group at the ICR and an honorary consultant in Haematology at The Royal Marsden NHS Foundation Trust.
Molecularly tailored therapy; improving diagnosis and outcomes for high-risk myeloma; high sensitivity functional MRI for improved management of myeloma; early diagnosis and prevention
years treating myeloma: 9
Number of Myeloma Patients Treated Annually:
Details & contact info
15 Cotswold Road, Sutton
London, UK, United Kingdom, SM2 5NG
Send a message to Martin Kaiser, FRCP, FRCPath, MD